Sepsis | CHOP Research Institute


Published on
Jun 2, 2022
CHOP and Penn researchers discussed the latest findings about the mechanisms of immunity at the CHOP Research Institute 2022 Scientific Symposium.

Dr. Woods-Hill researches diagnostic and treatment decision-making in the critical care setting, with a specific interest on the impact of these decisions on unintended patient harm and medical overuse. She focuses on bacterial bloodstream infections in children in the PICU, and diagnostic stewardship in this context.

woodshillc [at]
Published on
Apr 1, 2022
Learn about earn about a regional research collaboration, prestigious awards, and listen to a special podcast series.

Dr. Perate is an anesthesiologist with a specialty in Neuroanesthesia at Children's Hospital of Philadelphia, an associate director with the CHOP Trauma Center, and an assistant professor of Clinical Anesthesiology and Critical Care. Dr. Perate's research focuses on sepsis and adaptive immunity.

peratea [at]
Published on
Oct 5, 2021
CHOP researchers identify the bacterial pathogens most responsible for early-onset sepsis in very preterm infants.

The office of the Colket Chair provides leadership in synergizing interprofessional research between CHOP and PENN Nursing and generates knowledge that supports patient and family healing, their healthcare experience, and clinical outcomes.

Published on
Jan 8, 2021
This week’s research news features CHOP’s participation in a study that found outcome disparities by race/ethnicity in children with severe sepsis.
Published on
Jan 4, 2021
Researchers work to enhance the body’s immune response to contain infection locally and prevent systemic bacterial spread.

The Downes Lab studies pediatric antimicrobial pharmacokinetics/pharmacodynamics (PK/PD) and pharmacoepidemiology with a focus on the relationship between antibiotic dosing/exposures and outcomes, including clinical cure, adverse events, and the development of antimicrobial resistance.

Published on
Aug 28, 2020
This week, we feature findings on the pandemic’s impact on mental health and asthma visits, a new high-risk tumor treatment, and more.